Caption – Sleep Apnea Detection was introduced by Samsung in the Galaxy Watch 7 and the Galaxy Watch Ultra for the first time. (Image credit – Samsung)
Samsung is making sure one of its most important smartwatch health features is more accessible. The Sleep Apnea detection in Galaxy Watches is now rolling out to 36 new countries, which includes 34 across Europe, plus Australia and Singapore. This feature was first introduced on the Galaxy Watch 7 and Galaxy Watch Ultra in the U.S. and is now finally going global.
In a newsroom post, Samsung shared that the Sleep Apnea detection tool has received CE (Conformité Européenne) certification for the European Economic Area. That means it meets the EU’s standards for health, safety, and environmental protection, clearing the way for the wider release.
The feature is available via the Samsung Health Monitor app, using the Galaxy Watch’s BioActive Sensor. It’s designed to detect signs of moderate to severe obstructive sleep apnea, offering insights that could encourage users to seek medical advice if needed.
Samsung highlights that this feature has already received De Novo authorisation from the U.S. FDA and is also approved by South Korea’s Ministry of Food and Drug Safety, Brazil’s ANVISA and Health Canada. That gives it credibility in multiple regions as a helpful screening tool.
To use it, you’ll need a Galaxy Watch running Wear OS 5.0 or later, paired with a phone using Android 9.0 or newer. The watch needs to track two sleep cycles before it can show results, as it uses that data to check for breathing irregularities during sleep.
However, Samsung is clear that this is not a medical device. The data from your watch should be viewed as a prompt to seek medical advice, not a confirmed diagnosis. If your watch suggests possible sleep apnea, it’s best to consult a healthcare professional.
Answer. It is available via the Samsung Health Monitor app, using the Galaxy Watch’s BioActive Sensor to track two sleep cycles and detect moderate to severe sleep apnea.
Answer. The feature is now rolling out to 36 more countries, including 34 European nations, Australia, and Singapore, after receiving CE certification for the EU.
Answer. No, Samsung clarifies that this tool is not a confirmed medical diagnosis. It serves as a screening feature and advises users to consult a healthcare professional.
Also Read: Samsung Galaxy Watch8 to feature familiar Exynos W1000 chip
Also Read: Leaked images hint at design change for Samsung Galaxy Watch 8 series
Highlights 8GB RAM Phones Under ₹20,000 in India - Moto G37 Power 5G, Moto G86…
Highlights Google will unveil the Pixel 11 series globally on August 12, 2026 in New…
Highlights Vivo S2 will debut in India on August 6 at 12pm IST via Vivo…
Highlights Upcoming Vivo Phones - While the Vivo S2 5G is set to launch first,…
Highlights If you're looking specifically for the highest zoom capability, the Vivo X300 Ultra leads…
Highlights Motorola has launched the Moto Pad 70 Groove tablet in India at ₹33,999 after…
This website uses cookies.